Clinical Trial Update: KN035 in Patients With Advanced Multiple Primary Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KN035 in patients with advanced multiple primary tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Primary Neoplasm

Drugs mentioned

• KN035

Snippet

Sponsor: RenJi Hospital | Conditions: Multiple Primary Neoplasm | Phase 2 | Status: UNKNOWN